Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 99

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Tuberous sclerosis

Yates, John R W · 2006 · European Journal of Human Genetics

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.ejhg.5201625

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. Curatolo P (ed): Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. London: Mac Keith Press, 2003.
  2. Guertin DA, Sabatini DM : An expanding role for mTOR in cancer. Trends Mol Med 2005; 11: 353–361. · DOI · Paper page
  3. Inoki K, Corradetti MN, Guan KL : Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005; 37: 19–24. · DOI · Paper page
  4. Yates JRW : Tuberous Sclerosis; in Cassidy SB, Allanson JE (eds): Management of Genetic Syndromes. Hoboken, New Jersey: John Wiley & Sons, 2005.
  5. Gomez MR, Sampson JR, Whittemore VH (eds): Tuberous Sclerosis Complex. Oxford: Oxford University Press, 1999. · DOI · Paper page
  6. Joinson C, O'Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF : Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 2003; 33: 335–344. · DOI · Paper page
  7. O'Callaghan FJ, Harris T, Joinson C et al: The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex. Arch Dis Child 2004; 89: 530–533. · DOI · Paper page
  8. Gillberg IC, Gillberg C, Ahlsen G : Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol 1994; 36: 50–56. · DOI · Paper page
  9. Shepherd CW, Houser OW, Gomez MR : MR findings in tuberous sclerosis complex and correlation with seizure development and mental impairment. Am J Neuroradiol 1995; 16: 149–155.
  10. Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A : Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002; 125: 1247–1255. · DOI · Paper page
  11. Rowley SA, O'Callaghan FJ, Osborne JP : Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 2001; 85: 420–423. · DOI · Paper page
  12. Tworetzky W, McElhinney DB, Margossian R et al: Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol 2003; 92: 487–489. · DOI · Paper page
  13. Sampson JR, Maheshwar MM, Aspinwall R et al: Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997; 61: 843–851. · DOI · Paper page
  14. Nelson CP, Sanda MG : Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002; 168: 1315–1325. · DOI · Paper page
  15. Hancock E, Tomkins S, Sampson J, Osborne J : Lymphangioleiomyomatosis and tuberous sclerosis. Respir Med 2002; 96: 7–13. · DOI
  16. Roach ES, Gomez MR, Northrup H : Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998; 13: 624–628. · DOI · Paper page
  17. Kwiatkowska J, Wigowska-Sowinska J, Napierala D, Slomski R, Kwiatkowski DJ : Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis. N Engl J Med 1999; 340: 703–707. · DOI
  18. Jones AC, Shyamsundar MM, Thomas MW et al: Comprehensive mutation analysis of TSC1 and TSC2 – and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999; 64: 1305–1315. · DOI · Paper page
  19. Dabora SL, Jozwiak S, Franz DN et al: Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001; 68: 64–80. · DOI · Paper page
  20. Sancak O, Nellist M, Goedbloed M et al: Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype – phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet 2005; 13: 731–741. · DOI · Paper page
  21. Lewis JC, Thomas HV, Murphy KC, Sampson JR : Genotype and psychological phenotype in tuberous sclerosis. J Med Genet 2004; 41: 203–207. · DOI
  22. Mayer K, Goedbloed M, van Zijl K, Nellist M, Rott HD : Characterisation of a novel TSC2 missense mutation in the GAP related domain associated with minimal clinical manifestations of tuberous sclerosis. J Med Genet 2004; 41: e64. · DOI
  23. O'Connor SE, Kwiatkowski DJ, Roberts PS, Wollmann RL, Huttenlocher PR : A family with seizures and minor features of tuberous sclerosis and a novel TSC2 mutation. Neurology 2003; 61: 409–412. · DOI
  24. Dabora SL, Roberts P, Nieto A et al: Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. Am J Hum Genet 2002; 71: 750–758. · DOI
  25. Verhoef S, Bakker L, Tempelaars AM et al: High rate of mosaicism in tuberous sclerosis complex. Am J Hum Genet 1999; 64: 1632–1637. · DOI · Paper page
  26. Yates JR, van Bakel I, Sepp T et al: Female germline mosaicism in tuberous sclerosis confirmed by molecular genetic analysis. Hum Mol Genet 1997; 6: 2265–2269. · DOI
  27. Green AJ, Johnson PH, Yates JR : The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 1994; 3: 1833–1834. · DOI · Paper page
  28. Green AJ, Smith M, Yates JR : Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 1994; 6: 193–196. · DOI · Paper page
  29. Carsillo T, Astrinidis A, Henske EP : Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000; 97: 6085–6090. · DOI · Paper page
  30. Yu J, Astrinidis A, Henske EP : Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001; 164: 1537–1540. · DOI · Paper page
  31. Plank TL, Yeung RS, Henske EP : Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 1998; 58: 4766–4770.
  32. Manning BD, Cantley LC : Rheb fills a GAP between TSC and TOR. Trends Biochem Sci 2003; 28: 573–576. · DOI · Paper page
  33. Kwiatkowski DJ, Manning BD : Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet 2005; 14 (Spec no. 2): R251–R258. · DOI · Paper page
  34. Kenerson H, Dundon TA, Yeung RS : Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 2005; 57: 67–75. · DOI · Paper page
  35. Lee L, Sudentas P, Donohue B et al: Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer 2005; 42: 213–227. · DOI · Paper page
  36. Roach ES, DiMario FJ, Kandt RS, Northrup H : Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999; 14: 401–407. · DOI · Paper page
  37. Hancock E, Osborne JP : Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999; 14: 71–74. · DOI
  38. Vanhatalo S, Nousiainen I, Eriksson K et al: Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002; 43: 748–756. · DOI
  39. Jarrar RG, Buchhalter JR, Raffel C : Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 2004; 62: 479–481. · DOI
  40. Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV : Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 2001; 25: 213–216. · DOI
  41. Torres OA, Roach ES, Delgado MR et al: Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. J Child Neurol 1998; 13: 173–177. · DOI
  42. Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA : Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005; 65: 235–238. · DOI
  43. Papadavid E, Markey A, Bellaney G, Walker NP : Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol 2002; 147: 337–342. · DOI
  44. Johnson SR, Tattersfield AE : Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55: 1052–1057. · DOI · Paper page
  45. Kothary N, Soulen MC, Clark TW et al: Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol 2005; 16: 45–50. · DOI · Paper page
  46. Dickinson M, Ruckle H, Beaghler M, Hadley HR : Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 1998; 49: 281–286.
  47. Roach ES, Kerr J, Mendelsohn D, Laster DW, Raeside C : Detection of tuberous sclerosis in parents by magnetic resonance imaging. Neurology 1991; 41: 262–265. · doi:10.1212/wnl.41.2_part_1.262
  48. Fryer AE, Chalmers AH, Osborne JP : The value of investigation for genetic counselling in tuberous sclerosis. J Med Genet 1990; 27: 217–223. · DOI
  49. Levine D, Barnes P, Korf B, Edelman R : Tuberous sclerosis in the fetus: second-trimester diagnosis of subependymal tubers with ultrafast MR imaging. Am J Roentgenol 2000; 175: 1067–1069. · DOI

Cited by

See all 99

Metadata

Authors
Yates, J. R. W.
Venue
European Journal of Human Genetics
Published
2006-07-26
Volume
14
Issue
10
Pages
1065-1073
ISSN
  • 1018-4813
  • 1476-5438
Cited by
99
References
3
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tuberous sclerosis. https://app.cochat.ai/papers/10.1038/sj.ejhg.5201625
The paper
Yates, J. R. W. (2006). Tuberous sclerosis. European Journal of Human Genetics. https://doi.org/10.1038/sj.ejhg.5201625

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.